NUCLIDIUM AG reposted this
💡 Unlocking PET Tracer Potential with Copper-61 at ESRR 2024 in Coimbra, April 18-21 💡 Copper-61 is a highly desirable radionuclide for labeling #PET tracers in pre-clinical and clinical settings. It has a half-life of 3.33 hours and is a favorable positron emitter (61% β+, Emax = 1.216 MeV). Its moderate 3.33-hour half-life offers an advantage over existing clinical tracers, enabling PET scans at extended post-injection intervals. At #ESRR24, Dr. Markus Baier and Dr. Nicole Schubert will showcase a method for producing [61Cu]CuCl2, a #radiopharmaceutical precursor with exceptional specificity, #radionuclide purity, and yield. Furthermore, we'll present the synthesis of [61Cu]Cu-NuriPro, a PSMA-targeting PET radiotracer, highlighting its first successful application. Join us on our journey, we would love to collaborate with you! For more information, contact us at info@nuclidium.com
